Cargando…

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Oxidative agents can cause acute haemolytic anaemia in persons with G6PD deficiency. Understanding the relationship between G6PD genotype and the phenotypic expression of the enzyme deficiency is necessary so that severe haemolysis can be avoided. The patterns of oxidative haemolysis have been well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Cindy S., Bancone, Germana, Nosten, François, White, Nicholas J., Luzzatto, Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833093/ https://www.ncbi.nlm.nih.gov/pubmed/29499733 http://dx.doi.org/10.1186/s12936-018-2248-y

Ejemplares similares

Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens
por: Chu, Cindy S., et al.
Publicado: (2017)

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
por: Chu, Cindy S., et al.
Publicado: (2019)

Modelling primaquine-induced haemolysis in G6PD deficiency
por: Watson, James, et al.
Publicado: (2017)

Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects
por: Bancone, Germana, et al.
Publicado: (2016)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers
por: Rueangweerayut, Ronnatrai, et al.
Publicado: (2017)

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
por: Avalos, Sara, et al.
Publicado: (2018)

The reality of using primaquine
por: Burgoine, Kathy L, et al.
Publicado: (2010)

Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
por: Devine, Angela, et al.
Publicado: (2017)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
por: White, Nicholas J, et al.
Publicado: (2012)

The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects
por: Bancone, Germana, et al.
Publicado: (2017)

Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border
por: Bancone, Germana, et al.
Publicado: (2014)

No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
por: Schilling, William H.K., et al.
Publicado: (2020)

Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures
por: Gilder, Mary Ellen, et al.
Publicado: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression
por: Kalnoky, Michael, et al.
Publicado: (2018)

Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests
por: Bancone, Germana, et al.
Publicado: (2015)

Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development
por: Bancone, Germana, et al.
Publicado: (2017)

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood
por: Bancone, Germana, et al.
Publicado: (2018)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications
por: Luzzatto, Lucio, et al.
Publicado: (2014)

Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
por: Anderle, Athena, et al.
Publicado: (2018)

G6PD Deficiency and Harilaou Variant in a Newborn: Intrauterine Haemolysis and Meconium Aspiration Syndrome
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2021)

Development of a new software tool and analysis method to improve determination of G6PD status
por: Kalnoky, Michael, et al.
Publicado: (2014)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient
por: Pal, Sampa, et al.
Publicado: (2019)

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
por: Uthman, Olalekan A., et al.
Publicado: (2017)

Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2019)

Chloroquine–Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2017)

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2021)

Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study
por: Thielemans, Laurence, et al.
Publicado: (2018)

Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar
por: Oo, Nwe Nwe, et al.
Publicado: (2016)

Barriers to routine G6PD testing prior to treatment with primaquine
por: Ley, Benedikt, et al.
Publicado: (2017)

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019)

X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
por: Guindo, Aldiouma, et al.
Publicado: (2007)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Reduction of Missed Diagnosis of G6PD Deficiency in Heterozygous Females by G6PD/6PGD Ratio Assay Combined with Amplification Refractory Mutation System PCR
por: Chen, Shiguo, et al.
Publicado: (2022)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_oesvt7ahciburtnbecu9ak2fa6